608 related articles for article (PubMed ID: 23017648)
21. Analysis of colonic alpha-synuclein pathology in multiple system atrophy.
Pouclet H; Lebouvier T; Coron E; Rouaud T; Flamant M; Toulgoat F; Roy M; Vavasseur F; Bruley des Varannes S; Neunlist M; Derkinderen P
Parkinsonism Relat Disord; 2012 Aug; 18(7):893-5. PubMed ID: 22560049
[TBL] [Abstract][Full Text] [Related]
22. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
23. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
24. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
25. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
Jellinger KA
Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
[TBL] [Abstract][Full Text] [Related]
26. Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.
Pascale E; Passarelli E; Purcaro C; Vestri AR; Fakeri A; Guglielmi R; Passarelli F; Meco G
Acta Neurol Scand; 2011 Sep; 124(3):176-81. PubMed ID: 20880267
[TBL] [Abstract][Full Text] [Related]
27. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
[TBL] [Abstract][Full Text] [Related]
28. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
29. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
[TBL] [Abstract][Full Text] [Related]
30. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
Mochizuki A; Komatsuzaki Y; Shoji S
Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
[TBL] [Abstract][Full Text] [Related]
31. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.
Iacovelli E; Gilio F; Meco G; Fattapposta F; Vanacore N; Brusa L; Giacomelli E; Gabriele M; Rubino A; Locuratolo N; Iani C; Pichiorri F; Colosimo C; Carbone A; Palleschi G; Inghilleri M
Mov Disord; 2010 Jul; 25(9):1203-9. PubMed ID: 20310046
[TBL] [Abstract][Full Text] [Related]
32. Colonic neuropathology is independent of olfactory dysfunction in Parkinson's disease.
Lebouvier T; Pouclet H; Coron E; Drouard A; N'Guyen JM; Roy M; Vavasseur F; Bruley des Varannes S; Damier P; Neunlist M; Derkinderen P; Rouaud T
J Parkinsons Dis; 2011; 1(4):389-94. PubMed ID: 23939345
[TBL] [Abstract][Full Text] [Related]
33. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of cytokines in painful and painless neuropathies.
Uçeyler N; Rogausch JP; Toyka KV; Sommer C
Neurology; 2007 Jul; 69(1):42-9. PubMed ID: 17606879
[TBL] [Abstract][Full Text] [Related]
35. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases.
Del Tredici K; Duda JE
J Neurol Sci; 2011 Nov; 310(1-2):100-6. PubMed ID: 21689832
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.
Koziorowski D; Tomasiuk R; Szlufik S; Friedman A
Cytokine; 2012 Dec; 60(3):762-6. PubMed ID: 22910321
[TBL] [Abstract][Full Text] [Related]
37. Circulating interleukin-10 and interleukin-12 in Parkinson's disease.
Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
Acta Neurol Scand; 2009 May; 119(5):332-7. PubMed ID: 18976327
[TBL] [Abstract][Full Text] [Related]
38. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
39. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
Jellinger KA
Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
[TBL] [Abstract][Full Text] [Related]
40. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]